Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease

BackgroundInflammatory cytokines have been considered to be significant factors contributing to the development and progression of non-alcoholic fatty liver disease (NAFLD). However, the role of inflammatory cytokines in NAFLD remains inconclusive.ObjectiveThis study aimed to evaluate the associatio...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Yamei Duan, Xiongfeng Pan, Jiayou Luo, Xiang Xiao, Jingya Li, Prince L. Bestman, Miyang Luo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Subjects:	inflammatory cytokines non-alcoholic fatty liver disease non-alcoholic steatohepatitis hepatic steatosis hepatic fibrosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.880298/full

Similar Items

Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review
by: Huanqiu Wang, et al.
Published: (2022-08-01)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
by: Youwen Tan, et al.
Published: (2024-12-01)

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Published: (2012-04-01)

SMYD2 inhibitors have no effect in improving non-alcoholic steatohepatitis in mice
by: Lanzexin Yang, et al.
Published: (2025-06-01)

Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
by: Svintsitskyy A., et al.
Published: (2016-07-01)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-12-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01)

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease
by: V.N. dos Santos, et al.
Published: (2005-05-01)

A CLINICAL CASE OF DRUG HEPATITIS A WOMAN WHO IS PREGNANT WITH OBESITY
by: I. O. Makarov, et al.
Published: (2016-05-01)

Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis
by: Weiwei He, et al.
Published: (2023-01-01)

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
by: Yan Huang, et al.
Published: (2022-01-01)

Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01)

SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
by: I. E. Belaya, et al.
Published: (2015-12-01)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
by: Seul Ki Han, et al.
Published: (2023-07-01)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
by: Janet Sánchez-Quevedo, et al.
Published: (2022-09-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
by: Carlo Smirne, et al.
Published: (2020-11-01)

The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
by: Ioana-Cristina Bica, et al.
Published: (2023-06-01)

Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
by: Kalliopi Zachou, et al.
Published: (2023-08-01)

Esteatosis hepática metabólica y nefropatía diabética: una llamada a la acción
by: Salvador Benlloch, et al.
Published: (2024-03-01)

The relationship between diabetes mellitus and non-alcoholic fatty liver disease: a clinical and instrumental paired study
by: Armida N. Sasunova, et al.
Published: (2024-09-01)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
by: Yu Ogino, et al.
Published: (2021-08-01)

Platelets in Non-alcoholic Fatty Liver Disease
by: Andrea Dalbeni, et al.
Published: (2022-02-01)

Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage
by: Sumit Kumar Anand, et al.
Published: (2022-07-01)

Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison
by: Fábio Henrique Ribeiro Maldonado, et al.
Published: (2023-06-01)

Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes
by: Georgiana-Diana Cazac, et al.
Published: (2022-09-01)

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
by: Hyeok-Hee Lee, et al.
Published: (2020-06-01)

Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis
by: Nancy Magee, et al.
Published: (2022-12-01)

Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
by: Hye Kyung Hyun, et al.
Published: (2024-03-01)

Alcoholic liver disease: State-of-the-art
by: I V Maev, et al.
Published: (2014-04-01)

Adherence to plant based diets reduce the risk of hepatic fibrosis in nonalcoholic fatty liver disease
by: Mahsa Miryan, et al.
Published: (2025-05-01)

Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease
by: Ling-Zi Chen, et al.
Published: (2024-09-01)

Biochemical and histological changes in two nonalcoholic fatty liver disease models of different severity
by: T. V. Brus, et al.
Published: (2024-07-01)

Lipid metabolism in patients with chronic hepatitis C, non-alcoholic fatty liver disease and obesity under the influence of treatment
by: M.A. Derbak, et al.
Published: (2024-04-01)

Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
by: Sandra Steensels, et al.
Published: (2020-07-01)

Combination of autoimmune hepatitis to non-alcoholic steatohepatitis (Clinical case)
by: A. A. Driga, et al.
Published: (2010-11-01)

The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo, Egypt
by: Alaa Ahmed Abd El Hamid, et al.
Published: (2024-10-01)

Correlation between CT Abdominal Anthropometric Measurements and Liver Density in Individuals with Non-Alcoholic Fatty Liver Disease
by: Dragoș Constantin Cucoranu, et al.
Published: (2023-03-01)

Prevalence of non-alcoholic fat disease liver in Russian Federation: meta-analysis
by: Igor V. Maev, et al.
Published: (2023-08-01)

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01)